Related Experiment Video
Updated: May 5, 2026

Image-guided, Laser-based Fabrication of Vascular-derived Microfluidic Networks
Published on: January 3, 2017
Dopamine and alkylated silica functionalized Janus gauze with fluid control capability for rapid hemostasis
Qingheng Wu1, Yimeng Cai1, Ke Xu1
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Abstract:
Hemorrhage caused by trauma is a global public health issue. While traditional cotton gauze compression is commonly used for hemostasis, its efficacy is limited in severe hemorrhage cases. Herein, we developed a gauze with Janus wettability (JW-G). Its surface was sequentially dip-coated with hydrophilic polydopamine and then spray-coated with hydrophobic silicon dioxide nanoparticles. Benefiting from the asymmetric surface wettability, the obtained JW-G could control blood flow direction and permeation speed. JW-G's hydrophobic surface concentrates blood cells and facilitate faster clot formation in vitro. Meanwhile, the silicon dioxide nanoparticles could also activate coagulation factor XII. Therefore, the JW-G greatly accelerates the hemostasis. In vivo bleeding model further demonstrated JW-G's good performance in reducing bleeding time and blood loss compared with commercial hemostatic gauze. The present strategy to develop hemostatic gauze offers a promising solution for reversing the adverse outcomes of severe traumatic hemorrhage.
Related Concept Videos
Positive Regulator Molecules
The Blood-brain Barrier
Blood Flow
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Modified-Release Drug Delivery Systems: Rate-Programmed I

